Morteza Bashash, Joseph M. Connors, Randy D. Gascoyne, Barbara Meissner, Johanna M. Schuetz, Stephen Leach, Graham W. Slack, Brian R. Berry, Howard Hu, Laurie H. Sehn, Angela R. Brooks-Wilson and John J. Spinelli (2017) “Genetic polymorphism at BCL2 as a predictor for rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone efficacy in patients with diffuse large B-cell lymphoma”, Haematologica. Pavia, Italy, 102(5), pp. e199-e202. doi: 10.3324/haematol.2016.159087.